These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36440216)

  • 21. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
    Stubbins RJ; Korotev S; Godley LA
    Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and Erythrocytosis.
    Korpershoek E; Koffy D; Eussen BH; Oudijk L; Papathomas TG; van Nederveen FH; Belt EJ; Franssen GJ; Restuccia DF; Krol NM; van der Luijt RB; Feelders RA; Oldenburg RA; van Ijcken WF; de Klein A; de Herder WW; de Krijger RR; Dinjens WN
    J Clin Endocrinol Metab; 2016 Feb; 101(2):453-60. PubMed ID: 26670126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors.
    AlDubayan SH; Pyle LC; Gamulin M; Kulis T; Moore ND; Taylor-Weiner A; Hamid AA; Reardon B; Wubbenhorst B; Godse R; Vaughn DJ; Jacobs LA; Meien S; Grgic M; Kastelan Z; Markt SC; Damrauer SM; Rader DJ; Kember RL; Loud JT; Kanetsky PA; Greene MH; Sweeney CJ; Kubisch C; Nathanson KL; Van Allen EM; Stewart DR; Lessel D;
    JAMA Oncol; 2019 Apr; 5(4):514-522. PubMed ID: 30676620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
    Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
    J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.
    Dénes J; Swords F; Rattenberry E; Stals K; Owens M; Cranston T; Xekouki P; Moran L; Kumar A; Wassif C; Fersht N; Baldeweg SE; Morris D; Lightman S; Agha A; Rees A; Grieve J; Powell M; Boguszewski CL; Dutta P; Thakker RV; Srirangalingam U; Thompson CJ; Druce M; Higham C; Davis J; Eeles R; Stevenson M; O'Sullivan B; Taniere P; Skordilis K; Gabrovska P; Barlier A; Webb SM; Aulinas A; Drake WM; Bevan JS; Preda C; Dalantaeva N; Ribeiro-Oliveira A; Garcia IT; Yordanova G; Iotova V; Evanson J; Grossman AB; Trouillas J; Ellard S; Stratakis CA; Maher ER; Roncaroli F; Korbonits M
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E531-41. PubMed ID: 25494863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Phenotype of Germline Pathogenic Variants in
    Chang X; Li Z; Ma X; Cui Y; Chen S; Tong A
    Front Endocrinol (Lausanne); 2020; 11():558. PubMed ID: 32973681
    [No Abstract]   [Full Text] [Related]  

  • 28. [Multiple Endocrine Neoplasia].
    Uchino S; Ito A
    Gan To Kagaku Ryoho; 2019 Jul; 46(7):1114-1118. PubMed ID: 31296813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Common Thread: A Case of Synchronous Lung Cancers and a Germline CHEK2 Mutation.
    Carey ET; Ferreira V; Shum E; Zhou F; Sabari JK
    Clin Lung Cancer; 2022 Jan; 23(1):e1-e4. PubMed ID: 34246541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
    Kim H; Cho DY; Choi DH; Oh M; Shin I; Park W; Huh SJ; Nam SJ; Lee JE; Kim SW
    Breast Cancer Res Treat; 2017 Jan; 161(1):95-102. PubMed ID: 27783279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics of pheochromocytoma and paraganglioma.
    Wachtel H; Fishbein L
    Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):283-290. PubMed ID: 33764930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
    Walsh T; Casadei S; Coats KH; Swisher E; Stray SM; Higgins J; Roach KC; Mandell J; Lee MK; Ciernikova S; Foretova L; Soucek P; King MC
    JAMA; 2006 Mar; 295(12):1379-88. PubMed ID: 16551709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pathogenic variant in CHEK2 shows a founder effect in Portuguese Roma patients with thyroid cancer.
    Pires C; Marques IJ; Dias D; Saramago A; Leite V; Cavaco BM
    Endocrine; 2021 Sep; 73(3):588-597. PubMed ID: 33683595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer.
    Chrisanthar R; Knappskog S; Løkkevik E; Anker G; Østenstad B; Lundgren S; Berge EO; Risberg T; Mjaaland I; Maehle L; Engebretsen LF; Lillehaug JR; Lønning PE
    PLoS One; 2008 Aug; 3(8):e3062. PubMed ID: 18725978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic loss of the remaining allele occurs approximately in half of CHEK2-driven breast cancers and is accompanied by a border-line increase of chromosomal instability.
    Iyevleva AG; Aleksakhina SN; Sokolenko AP; Baskina SV; Venina AR; Anisimova EI; Bizin IV; Ivantsov AO; Belysheva YV; Chernyakova AP; Togo AV; Imyanitov EN
    Breast Cancer Res Treat; 2022 Apr; 192(2):283-291. PubMed ID: 35020107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is
    De Silva DL; Winship I
    BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32900738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma.
    Lipton L; Fleischmann C; Sieber OM; Thomas HJ; Hodgson SV; Tomlinson IP; Houlston RS
    Cancer Lett; 2003 Oct; 200(2):149-52. PubMed ID: 14568168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between the Expression of CHK2 and p53 in Tumor Tissue and the Course of Papillary Thyroid Cancer in Patients with
    Gąsior-Perczak D; Kowalik A; Kopczyński J; Macek P; Niemyska K; Walczyk A; Gruszczyński K; Siołek M; Dróżdż T; Kosowski M; Pałyga I; Przybycień P; Wabik O; Góźdź S; Kowalska A
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers.
    Toss A; Tenedini E; Piombino C; Venturelli M; Marchi I; Gasparini E; Barbieri E; Razzaboni E; Domati F; Caggia F; Grandi G; Combi F; Tazzioli G; Dominici M; Tagliafico E; Cortesi L
    Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33919281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
    Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
    Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.